基于冠状动脉CT血管造影的钙化评分:新型虚拟非碘重建算法在临床第一代双源光子计数探测器系统上的体外与体内验证
本研究在钙化模型和67例接受CCTA的患者中,评估第一代光子计数探测器CT上新型虚拟非碘重建(PureCalcium)的冠状动脉钙化评分,并与虚拟非对比(VNC)和真实非对比(TNC)采集比较。PureCalcium的钙化评分与TNC相关性高但存在低估,VNC低估更明显;PureCalcium的钙化分类一致性(κ=0.88)优于VNC(κ=0.60)。
要点
- 在体研究显示PureCalcium钙化评分与TNC高度相关(r=0.97,ICC=0.98),但存在低估(平均偏差-113.5)。
- VNC钙化评分较TNC显著低估更严重(平均偏差-551.6),分类一致性仅κ=0.60。
- PureCalcium钙化分类与TNC一致性达κ=0.88,优于VNC。
核心结论
- 基于CCTA的PureCalcium重建在钙化评分定量和分类上的准确性优于VNC重建。
研究设计与样本
- 在钙化模型和67例患者(年龄70[59/80]岁,58.2%男性)中,于第一代光子计数探测器CT上比较PureCalcium、VNC和TNC三种重建的钙化评分。
诊断标准与关键数值
- 钙化评分分类为0、1-10、11-100、101-400和>400;模型研究中PureCalcium与TNC比较P=0.01、r=0.98、ICC=0.98、平均偏差6.6、一致性限-39.8/26.6,VNC与TNC比较P<0.001、r=0.94、ICC=0.89、平均偏差24.9、一致性限-87.1/37.2。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to evaluate coronary computed tomography angiography (CCTA)-based in vitro and in vivo coronary artery calcium scoring (CACS) using a novel virtual noniodine reconstruction (PureCalcium) on a clinical first-generation photon-counting detector-computed tomography system compared with virtual noncontrast (VNC) reconstructions and true noncontrast (TNC) acquisitions.
MATERIALS AND METHODS: Although CACS and CCTA are well-established techniques for the assessment of coronary artery disease, they are complementary acquisitions, translating into increased scan time and patient radiation dose. Hence, accurate CACS derived from a single CCTA acquisition would be highly desirable. In this study, CACS based on PureCalcium, VNC, and TNC, reconstructions was evaluated in a CACS phantom and in 67 patients (70 [59/80] years, 58.2% male) undergoing CCTA on a first-generation photon counting detector-computed tomography system. Coronary artery calcium scores were quantified for the 3 reconstructions and compared using Wilcoxon test. Agreement was evaluated by Pearson and Spearman correlation and Bland-Altman analysis. Classification of coronary artery calcium score categories (0, 1-10, 11-100, 101-400, and >400) was compared using Cohen κ .
RESULTS: Phantom studies demonstrated strong agreement between CACS PureCalcium and CACS TNC (60.7 ± 90.6 vs 67.3 ± 88.3, P = 0.01, r = 0.98, intraclass correlation [ICC] = 0.98; mean bias, 6.6; limits of agreement [LoA], -39.8/26.6), whereas CACS VNC showed a significant underestimation (42.4 ± 75.3 vs 67.3 ± 88.3, P < 0.001, r = 0.94, ICC = 0.89; mean bias, 24.9; LoA, -87.1/37.2). In vivo comparison confirmed a high correlation but revealed an underestimation of CACS PureCalcium (169.3 [0.7/969.4] vs 232.2 [26.5/1112.2], P < 0.001, r = 0.97, ICC = 0.98; mean bias, -113.5; LoA, -470.2/243.2). In comparison, CACS VNC showed a similarly high correlation, but a substantially larger underestimation (24.3 [0/272.3] vs 232.2 [26.5/1112.2], P < 0.001, r = 0.97, ICC = 0.54; mean bias, -551.6; LoA, -2037.5/934.4). CACS PureCalcium showed superior agreement of CACS classification ( κ = 0.88) than CACS VNC ( κ = 0.60).
CONCLUSIONS: The accuracy of CACS quantification and classification based on PureCalcium reconstructions of CCTA outperforms CACS derived from VNC reconstructions.
引用
- Emrich, Aquino, Schoepf, et al. Coronary Computed Tomography Angiography-Based Calcium Scoring: In Vitro and In Vivo Validation of a Novel Virtual Noniodine Reconstruction Algorithm on a Clinical, First-Generation Dual-Source Photon Counting-Detector System. Invest Radiol. 2022. PMID: 35318969. doi:10.1097/RLI.0000000000000868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。